Embecta Corp. (EMBC)

Market Cap	725.27M
Revenue (ttm)	1.08B
Net Income (ttm)	52.80M
Shares Out	58.44M
EPS (ttm)	0.89
PE Ratio	13.42
Forward PE	4.09
Dividend	$0.60 (4.86%)
Ex-Dividend Date	May 28, 2025

Volume	930,296
Open	12.37
Previous Close	11.97
Day's Range	11.98 - 12.61
52-Week Range	10.12 - 21.48
Beta	1.19
Analysts	Hold
Price Target	17.67 (+42.33%)
Earnings Date	May 9, 2025

About EMBC

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally. The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1924
• Employees: 2,100
• Stock Exchange: NASDAQ
• Ticker Symbol: EMBC
• Website: https://www.embecta.com

Financial Performance

In 2024, Embecta's revenue was $1.12 billion, an increase of 0.21% compared to the previous year's $1.12 billion. Earnings were $78.30 million, an increase of 11.22%.

Analyst Forecast

According to 3 analysts, the average rating for EMBC stock is "Hold." The 12-month stock price forecast is $17.67, which is an increase of 42.33% from the latest price.

Price Target

$17.67

(42.33% upside)

Analyst Consensus: Hold